No, FibroScan is NOT a Blood Test
FibroScan is an ultrasound-based imaging device that measures liver stiffness using vibration-controlled transient elastography (VCTE), not a blood test. 1, 2
What FibroScan Actually Is
FibroScan uses transient elastography technology to measure liver stiffness by assessing how ultrasound waves propagate through liver tissue 3. The device:
- Measures liver stiffness in kilopascals (kPa) to assess fibrosis
- Can be performed at bedside or in outpatient clinics with immediate results 4
- Was FDA-approved in 2013 for assessing liver disease 2, 5
- Also measures the Controlled Attenuation Parameter (CAP) to assess liver fat content 6, 7
Blood Tests vs. FibroScan: The Key Distinction
The guidelines clearly differentiate between blood-based fibrosis tests and imaging-based tests like FibroScan 1:
Blood-Based Tests Include:
- FIB-4 score (uses age, AST, ALT, platelet count)
- APRI (AST-to-platelet ratio index)
- FibroTest (proprietary serum biomarkers)
- Enhanced Liver Fibrosis (ELF) panel (measures matrix turnover proteins)
Imaging-Based Tests Include:
- FibroScan (VCTE) - the subject of your question
- MR elastography (MRE)
- Acoustic radiation force impulse (ARFI)
Clinical Performance
FibroScan demonstrates superior diagnostic accuracy compared to blood tests 1:
- AUROC consistently >0.9 for detecting cirrhosis 1
- Sensitivity of 87% and specificity of 91% for diagnosing cirrhosis 8
- More accurate than blood-based biomarkers for advanced fibrosis 9
Common Pitfalls to Avoid
Do not confuse FibroScan with blood tests simply because both are "non-invasive." Key limitations of FibroScan include 2, 8:
- Cannot be used accurately in patients with ascites, morbid obesity, or significant chest wall fat
- Results can be falsely elevated by active inflammation, recent food intake, or extrahepatic cholestasis 2, 8
- Requires specialized equipment, annual recalibration, and formal training 1
- Failure rate of approximately 5-10% 9, 4
Two-Tier Risk Stratification Approach
Current guidelines recommend a sequential testing strategy 10, 11:
- First tier: Use blood-based scores (FIB-4 or NAFLD Fibrosis Score) as initial screening
- Second tier: Perform FibroScan for patients with indeterminate or high blood test scores
This approach is more accurate and cost-effective than using either test alone 10.